798 related articles for article (PubMed ID: 33523846)
21. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.
Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088
[TBL] [Abstract][Full Text] [Related]
22. N-glycan structures of human alveoli provide insight into influenza A virus infection and pathogenesis.
Sriwilaijaroen N; Nakakita SI; Kondo S; Yagi H; Kato K; Murata T; Hiramatsu H; Kawahara T; Watanabe Y; Kanai Y; Ono T; Hirabayashi J; Matsumoto K; Suzuki Y
FEBS J; 2018 May; 285(9):1611-1634. PubMed ID: 29542865
[TBL] [Abstract][Full Text] [Related]
23. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
24. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening.
Nile SH; Kim DH; Nile A; Park GS; Gansukh E; Kai G
Food Chem Toxicol; 2020 Jan; 135():110985. PubMed ID: 31765700
[TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
[TBL] [Abstract][Full Text] [Related]
26. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
Choudhary S; Malik YS; Tomar S
Front Immunol; 2020; 11():1664. PubMed ID: 32754161
[TBL] [Abstract][Full Text] [Related]
27. Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro.
Chang SY; Cruz DJ; Ko Y; Min JY
Biochem Biophys Res Commun; 2016 Sep; 478(4):1594-601. PubMed ID: 27586275
[TBL] [Abstract][Full Text] [Related]
28. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
29. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
Chlanda P; Mekhedov E; Waters H; Sodt A; Schwartz C; Nair V; Blank PS; Zimmerberg J
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794042
[TBL] [Abstract][Full Text] [Related]
30. Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral Hemagglutinin.
Sato Y; Morimoto K; Kubo T; Sakaguchi T; Nishizono A; Hirayama M; Hori K
Mar Drugs; 2015 May; 13(6):3454-65. PubMed ID: 26035023
[TBL] [Abstract][Full Text] [Related]
31. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
32. Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery.
Sakai T; Nishimura SI; Naito T; Saito M
Sci Rep; 2017 Mar; 7():45043. PubMed ID: 28344335
[TBL] [Abstract][Full Text] [Related]
33. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
Liu YM; Shahed-Al-Mahmud M; Chen X; Chen TH; Liao KS; Lo JM; Wu YM; Ho MC; Wu CY; Wong CH; Jan JT; Ma C
Cell Rep; 2020 Aug; 32(6):108016. PubMed ID: 32755598
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
[TBL] [Abstract][Full Text] [Related]
35. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
36. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
[TBL] [Abstract][Full Text] [Related]
37. Recent strategies in the search for new anti-influenza therapies.
Wilson JC; von Itzstein M
Curr Drug Targets; 2003 Jul; 4(5):389-408. PubMed ID: 12816348
[TBL] [Abstract][Full Text] [Related]
38. Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.
Abed Y; Bourgault AM; Fenton RJ; Morley PJ; Gower D; Owens IJ; Tisdale M; Boivin G
J Infect Dis; 2002 Oct; 186(8):1074-80. PubMed ID: 12355356
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
40. Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.
Qian Z; Ou X; Góes LG; Osborne C; Castano A; Holmes KV; Dominguez SR
J Virol; 2015 Sep; 89(17):8816-27. PubMed ID: 26085157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
